Search

Displaying results 8201 - 8210 of 10000 in total
  1. Drug

    Atigliflozin

    go.drugbank.com/drugs/DB21394
    Investigational

    Atigliflozin is under investigation in clinical trial NCT00361738 (Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin Treatment).

  2. Drug

    Dazdotuftide

    go.drugbank.com/drugs/DB21550
    Investigational

    Dazdotuftide is under investigation in clinical trial NCT05042609 (A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma).

  3. Drug

    Muvalaplin

    go.drugbank.com/drugs/DB21568
    Investigational

    Muvalaplin is under investigation in clinical trial NCT05563246 (A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events).

  4. Drug

    Pocenbrodib

    go.drugbank.com/drugs/DB21616
    Investigational

    Pocenbrodib is under investigation in clinical trial NCT06785636 (Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617).

  5. Drug

    Desonide

    go.drugbank.com/drugs/DB01260
    ApprovedInvestigational

    A nonfluorinated corticosteroid anti-inflammatory agent used topically for dermatoses.

    Mixtures: APOLAR N, DESOLEX-N
  6. Drug

    Zoalene

    go.drugbank.com/drugs/DB11480
    ExperimentalVet approved

    Dinitolmide is a fodder additive for prophylaxis against coccidiosis infections in poultry.

  7. Drug

    Lunasine

    go.drugbank.com/drugs/DB16223
    Investigational

    Lunasine is under investigation in clinical trial NCT02709330 (ALS Reversals - Lunasin Regimen).

  8. Drug

    CT103A

    go.drugbank.com/drugs/DB18180
    Investigational

    CT103A is an investigational BCMA-targeted genetically modified autologous T-cell immunotherapy.

  9. Drug

    CT120

    go.drugbank.com/drugs/DB18181
    Investigational

    CT120 is an investigational autologous CD19/22 targeted CAR-T cell immunotherapy.

  10. Drug

    CAM-101

    go.drugbank.com/drugs/DB18414
    Investigational

    CAM-101 is an allogeneic human platelet lysate product depleted of fibrinogen.